LivaNova PLC (LIVN) Position Maintained by Platinum Investment Management Ltd.
Platinum Investment Management Ltd. maintained its position in LivaNova PLC (NASDAQ:LIVN) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 33,782 shares of the company’s stock at the close of the 2nd quarter. Platinum Investment Management Ltd. owned approximately 0.07% of LivaNova PLC worth $2,067,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. PNC Financial Services Group Inc. lifted its stake in shares of LivaNova PLC by 9.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock worth $105,000 after buying an additional 153 shares during the last quarter. Riverhead Capital Management LLC raised its stake in LivaNova PLC by 76.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 1,763 shares of the company’s stock worth $108,000 after purchasing an additional 763 shares in the last quarter. Exane Derivatives raised its stake in LivaNova PLC by 814.8% in the 2nd quarter. Exane Derivatives now owns 3,156 shares of the company’s stock worth $158,000 after purchasing an additional 2,811 shares in the last quarter. Teacher Retirement System of Texas acquired a new stake in LivaNova PLC in the 2nd quarter worth about $204,000. Finally, LS Investment Advisors LLC raised its stake in LivaNova PLC by 14.5% in the 2nd quarter. LS Investment Advisors LLC now owns 3,449 shares of the company’s stock worth $211,000 after purchasing an additional 436 shares in the last quarter. Institutional investors own 82.26% of the company’s stock.
Shares of LivaNova PLC (NASDAQ:LIVN) traded up 0.84% during trading on Friday, hitting $74.24. 308,800 shares of the stock traded hands. The stock has a 50-day moving average of $66.44 and a 200 day moving average of $59.78. The company has a market cap of $3.63 billion, a P/E ratio of 132.57 and a beta of 0.59. LivaNova PLC has a 1-year low of $40.83 and a 1-year high of $74.25.
LivaNova PLC (NASDAQ:LIVN) last announced its quarterly earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.19. LivaNova PLC had a net margin of 2.26% and a return on equity of 9.08%. The firm had revenue of $321.40 million for the quarter, compared to the consensus estimate of $315.75 million. The firm’s revenue was up .1% on a year-over-year basis. On average, equities research analysts predict that LivaNova PLC will post $3.25 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/livanova-plc-livn-position-maintained-by-platinum-investment-management-ltd/1618250.html.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $60.76, for a total value of $60,760.00. Following the sale, the director now directly owns 58,296 shares of the company’s stock, valued at $3,542,064.96. The sale was disclosed in a legal filing with the SEC, which is available at this link. Over the last three months, insiders sold 3,000 shares of company stock worth $190,860. Insiders own 0.28% of the company’s stock.
Several brokerages have weighed in on LIVN. Berenberg Bank reiterated a “buy” rating and issued a $70.00 price objective on shares of LivaNova PLC in a research note on Friday, August 11th. Jefferies Group LLC lifted their price objective on shares of LivaNova PLC from $76.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, September 15th. Needham & Company LLC upgraded shares of LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Friday, September 15th. Canaccord Genuity reiterated a “hold” rating and issued a $71.00 price objective on shares of LivaNova PLC in a research note on Wednesday, September 20th. Finally, BidaskClub cut shares of LivaNova PLC from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $71.50.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.